Impaired NRF2 Inhibits Recovery from Ischemic Reperfusion Injury in the Aging Kidney

Overview

Journal Antioxidants (Basel)

Date 2023 Jul 29

PMID 37507979

Authors

Min Jee Jo

Ji Eun Kim

So Yon Bae

Eunjung Cho

Shin Young Ahn

Young Joo Kwon

Gang-Jee Ko

Affiliations

Soon will be listed here.

Abstract

Deteriorating kidney function is frequently observed in the elderly population, as well as vulnerability to acute kidney failure, such as ischemic/reperfusion injury (IRI), and inadequate recovery from IRI is one of the mechanisms of kidney dysfunction in the elderly. The potential mediators in the progression of kidney dysfunction in the aging kidney have not yet been clearly revealed. In this study, we investigated the role of nuclear factor erythroid 2-related factor 2 (NRF2), which is an essential regulator of cellular redox homeostasis, in restoring kidney function after IRI in the aging kidney. NRF2 expression decreased significantly in the kidneys of old mice, as well as histologic and functional renal recovery after IRI; 45-min renal pedicle clamping was retarded in old compared with young mice. Persistent renal injury during the recovery phase after IRI was aggravated in NRF2 knockout (KO) mice compared to wild-type mice. Oxidative stress occurred in NRF2 KO old mice during the IRI recovery phase along with decreased expression of mitochondrial OXPHOS-related proteins and a reduction in mitochondrial ATP content. In vitro, hypoxia/reoxygenation (H/R) injury was aggravated in senescent human proximal tubuloepithelial cells after NRF2 restriction using NRF2 siRNA, which also increased the level of oxidative stress and deteriorated mitochondrial dysfunction. Treating the mice with an NRF2 activator, CDDO-Me, alleviated the injury. These results suggest that NRF2 may be a therapeutic target for the aging kidney.

Citing Articles

Ischemia-induced endogenous Nrf2/HO-1 axis activation modulates microglial polarization and restrains ischemic brain injury.

Kuo P, Weng W, Scofield B, Paraiso H, Yu I, Yen J Front Immunol. 2024; 15:1440592.

PMID: 39469715 PMC: 11513276. DOI: 10.3389/fimmu.2024.1440592.

Pathological mechanisms of kidney disease in ageing.

Yamamoto T, Isaka Y Nat Rev Nephrol. 2024; 20(9):603-615.

PMID: 39025993 DOI: 10.1038/s41581-024-00868-4.

NRF2 in kidney physiology and disease.

Bondi C, Hartman H, Tan R Physiol Rep. 2024; 12(5):e15961.

PMID: 38418382 PMC: 10901725. DOI: 10.14814/phy2.15961.

Molecular Mechanisms Associated with Aging Kidneys and Future Perspectives.

Jo M, Lee J, Kim J, Ko G Int J Mol Sci. 2023; 24(23).

PMID: 38069234 PMC: 10707287. DOI: 10.3390/ijms242316912.

References

Jankauskas S, Pevzner I, Andrianova N, Zorova L, Popkov V, Silachev D . The age-associated loss of ischemic preconditioning in the kidney is accompanied by mitochondrial dysfunction, increased protein acetylation and decreased autophagy. Sci Rep. 2017; 7:44430. PMC: 5353572. DOI: 10.1038/srep44430. View

Gomes P, Simao S, Silva E, Pinto V, Amaral J, Afonso J . Aging increases oxidative stress and renal expression of oxidant and antioxidant enzymes that are associated with an increased trend in systolic blood pressure. Oxid Med Cell Longev. 2010; 2(3):138-45. PMC: 2763239. DOI: 10.4161/oxim.2.3.8819. View

Amdur R, Chawla L, Amodeo S, Kimmel P, Palant C . Outcomes following diagnosis of acute renal failure in U.S. veterans: focus on acute tubular necrosis. Kidney Int. 2009; 76(10):1089-97. DOI: 10.1038/ki.2009.332. View

Keum Y, Choi B . Molecular and chemical regulation of the Keap1-Nrf2 signaling pathway. Molecules. 2014; 19(7):10074-89. PMC: 6270911. DOI: 10.3390/molecules190710074. View

Wei W, Ma N, Fan X, Yu Q, Ci X . The role of Nrf2 in acute kidney injury: Novel molecular mechanisms and therapeutic approaches. Free Radic Biol Med. 2020; 158:1-12. DOI: 10.1016/j.freeradbiomed.2020.06.025. View

Zahran M, Hussein A, Barakat N, Awadalla A, Khater S, Harraz A . Sildenafil activates antioxidant and antiapoptotic genes and inhibits proinflammatory cytokine genes in a rat model of renal ischemia/reperfusion injury. Int Urol Nephrol. 2015; 47(11):1907-15. DOI: 10.1007/s11255-015-1099-5. View

Bian A, Neyra J, Zhan M, Hu M . Klotho, stem cells, and aging. Clin Interv Aging. 2015; 10:1233-43. PMC: 4531025. DOI: 10.2147/CIA.S84978. View

Kocak C, Kocak F, Akcilar R, Bayat Z, Aras B, Metineren M . Effects of captopril, telmisartan and bardoxolone methyl (CDDO-Me) in ischemia-reperfusion-induced acute kidney injury in rats: an experimental comparative study. Clin Exp Pharmacol Physiol. 2015; 43(2):230-41. DOI: 10.1111/1440-1681.12511. View

Miao J, Liu J, Niu J, Zhang Y, Shen W, Luo C . Wnt/β-catenin/RAS signaling mediates age-related renal fibrosis and is associated with mitochondrial dysfunction. Aging Cell. 2019; 18(5):e13004. PMC: 6718575. DOI: 10.1111/acel.13004. View

10.

Sung B, Park S, Yu B, Young Chung H . Modulation of PPAR in aging, inflammation, and calorie restriction. J Gerontol A Biol Sci Med Sci. 2004; 59(10):997-1006. DOI: 10.1093/gerona/59.10.b997. View

11.

Yamamoto M, Kensler T, Motohashi H . The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis. Physiol Rev. 2018; 98(3):1169-1203. PMC: 9762786. DOI: 10.1152/physrev.00023.2017. View

12.

Li R, Jia Z, Zhu H . Regulation of Nrf2 Signaling. React Oxyg Species (Apex). 2019; 8(24):312-322. PMC: 6830569. View

13.

Trifunovic A, Larsson N . Mitochondrial dysfunction as a cause of ageing. J Intern Med. 2008; 263(2):167-78. DOI: 10.1111/j.1365-2796.2007.01905.x. View

14.

Lee S, Koh D, Won Jun D, Roh Y, Kang H, Oh J . Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways. Clin Mol Hepatol. 2022; 28(4):827-840. PMC: 9597229. DOI: 10.3350/cmh.2022.0068. View

15.

Kuro-O M . Klotho and the aging process. Korean J Intern Med. 2011; 26(2):113-22. PMC: 3110841. DOI: 10.3904/kjim.2011.26.2.113. View

16.

. Summary of Recommendation Statements. Kidney Int Suppl (2011). 2015; 3(1):5-14. PMC: 4284512. DOI: 10.1038/kisup.2012.77. View

17.

Yang H, Fogo A . Fibrosis and renal aging. Kidney Int Suppl (2011). 2015; 4(1):75-78. PMC: 4536965. DOI: 10.1038/kisup.2014.14. View

18.

Coca S . Acute kidney injury in elderly persons. Am J Kidney Dis. 2010; 56(1):122-31. PMC: 2902696. DOI: 10.1053/j.ajkd.2009.12.034. View

19.

Kim H, Nel A . The role of phase II antioxidant enzymes in protecting memory T cells from spontaneous apoptosis in young and old mice. J Immunol. 2005; 175(5):2948-59. DOI: 10.4049/jimmunol.175.5.2948. View

20.

Murtagh F, Burns A, Moranne O, Morton R, Naicker S . Supportive Care: Comprehensive Conservative Care in End-Stage Kidney Disease. Clin J Am Soc Nephrol. 2016; 11(10):1909-1914. PMC: 5053791. DOI: 10.2215/CJN.04840516. View